File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Patients with atrial fibrillation and diabetes: does apixaban remain the drug of choice?

TitlePatients with atrial fibrillation and diabetes: does apixaban remain the drug of choice?
Authors
Hai, SHJJTse, HF
Issue Date2015
PublisherOxford University Press. The Journal's web site is located at http://ehjcvp.oxfordjournals.org/
Citation
European Heart Journal - Cardiovascular Pharmacotherapy, 2015, v. 1 n. 2, p. 95-96 How to Cite?
DOI: http://dx.doi.org/10.1093/ehjcvp/pvv003
Persistent Identifierhttp://hdl.handle.net/10722/234705
ISSN
2055-6837
2021 Impact Factor: 11.177
2020 SCImago Journal Rankings: 1.895
ISI Accession Number ID
WOS:000218416100008

 

DC FieldValueLanguage
dc.contributor.authorHai, SHJJ-
dc.contributor.authorTse, HF-
dc.date.accessioned2016-10-14T13:48:45Z-
dc.date.available2016-10-14T13:48:45Z-
dc.date.issued2015-
dc.identifier.citationEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2015, v. 1 n. 2, p. 95-96-
dc.identifier.issn2055-6837-
dc.identifier.urihttp://hdl.handle.net/10722/234705-
dc.languageeng-
dc.publisherOxford University Press. The Journal's web site is located at http://ehjcvp.oxfordjournals.org/-
dc.relation.ispartofEuropean Heart Journal - Cardiovascular Pharmacotherapy-
dc.rightsPre-print: Journal Title] ©: [year] [owner as specified on the article] Published by Oxford University Press [on behalf of xxxxxx]. All rights reserved. Pre-print (Once an article is published, preprint notice should be amended to): This is an electronic version of an article published in [include the complete citation information for the final version of the Article as published in the print edition of the Journal.] Post-print: This is a pre-copy-editing, author-produced PDF of an article accepted for publication in [insert journal title] following peer review. The definitive publisher-authenticated version [insert complete citation information here] is available online at: xxxxxxx [insert URL that the author will receive upon publication here].-
dc.titlePatients with atrial fibrillation and diabetes: does apixaban remain the drug of choice?-
dc.typeArticle-
dc.identifier.emailHai, SHJJ: haishjj@hku.hk-
dc.identifier.emailTse, HF: hftse@hkucc.hku.hk-
dc.identifier.authorityHai, SHJJ=rp02047-
dc.identifier.authorityTse, HF=rp00428-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1093/ehjcvp/pvv003-
dc.identifier.hkuros269562-
dc.identifier.volume1-
dc.identifier.issue2-
dc.identifier.spage95-
dc.identifier.epage96-
dc.identifier.isiWOS:000218416100008-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl2055-6837-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats